Venture capital news - the latest biotech news from Labiotech.eu

Home Venture capital Page 8

Latest Posts

shutterstock 625855988

Interview 18 May 2017

#Live# Labiotech Hangout: Join our first webcast on anti-aging therapies!

As we grow as a company, our content is growing too! Hang out with us and anti-aging VC managing partner, James Peyer, online next week. Join Now! We can’t wait for an event to produce videos for our readers, and we realized we don’t have to! Next week, we’re trying out a new feature and bringing additional […]

May 18, 2017 - 1 minutemin - By Evelyn Warner

The Art of Pics

In Depth 27 Apr 2017

Spain: An Emerging Star in the European Biotech Community

Take note, Spain is becoming a new hotspot for biotech in Europe. More than €400M of venture capital, counting recent fundraising and anticipated closings, is forecasted to be available this year to fund the creation and growth of start-ups in the life sciences sector. Behind the growing interest among investors are novel opportunities with breakthrough potential […]

April 27, 2017 - 6 minutesmins - By External Contributor

IMG 0201 e1490119052891

Interview 22 Mar 2017

Watch a Partner at Spain’s Largest VC talk Investment Strategy

At BIO Europe Spring, we met Karen Wagner, a General Partner at Ysios, the VC dominating Spain’s investment scene. She told us what’s on the firm’s radar. Spain’s largest VC has positioned itself in Barcelona, having identified the city’s potential to be the next biotech hub in Europe. It has funded key biotechs in Spain, including Sanifit, which claimed the […]

March 22, 2017 - 2 minutesmins - By Evelyn Warner

Russ Cummings Touchstone Innovations Edited e1487839162471

Interview 20 Feb 2017

Investment CEO shares Tips for Academics on Succeeding in Business

With decades of experience, the CEO of Touchstone Innovations tells us about funding the development of academic projects into commercialized products Formerly known as Imperial Innovations, the investing arm of Imperial College in London has since morphed into Touchstone Innovations, an UK technology commercialization and investment company with the same core mission in bridging the gap […]

February 20, 2017 - 7 minutesmins - By Evelyn Warner

shutterstock 538174702

News and Trends 20 Dec 2016

These are our 10 Most Read Biotech Articles of 2016

From the hottest research areas to the most popular city for biotech, which biotech articles have managed to hook our readers the most this year? After an exciting journey of 2 years, Labiotech.eu is now the leading biotech media in Europe, with over 50k monthly readers. To celebrate the end of another amazing year, we wanted […]

December 20, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

gambling crispr investment drugs

News and Trends 15 Nov 2016

How much of a Gamble is Investing in CRISPR?

CRISPR is going to change a lot in the life science industry and is perceived as THE discovery of the 21st century. Within the past 6 months, 3 companies went public, raising between €50M and €100M each (with valuation close to the billion), to bring about the CRISPR revolution. But the problem is, there is absolutely […]

November 15, 2016 - 4 minutesmins - By Philip Hemme

ADVERTISEMENT

biogeneration capital ventures finance money fund biotech medtech

News and Trends 5 Jul 2016

The Fund behind the ‘Biggest Private Exit Ever’ to Raise another €50M

BioGeneration Ventures has had its first close of a new venture capital fund, ‘BioGeneration Capital Fund III’, for novel diagnostic, medtech and therapeutic biotechs in Europe. BioGeneration Ventures (BGV) is based in Naarden (Netherlands) and manages funds investing in Netherlands, Belgium and Germany. Some of its biotech porfolio companies have included Dezima Pharma (acquired by Amgen from […]

July 5, 2016 - 2 minutesmins - By Dani Bancroft

gilde healthcare fund 4 medtech biotech

News and Trends 15 Jun 2016

Dutch Fund raises €250M to invest in Late Stage Biotechs

Gilde Healthcare has raised €250M for its 4th fund in an oversubscribed round. The money will go to late-stage MedTech, digital health and therapeutics, which can join a portfolio with some of the European celebrity-Biotechs. Gilde Healthcare is based in Utrecht (Netherlands) and Cambridge (Massachussets), investing in healthcare companies on both sides of the Atlantic. This VC […]

June 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

europe biotech ey finance growth pharma industry 2016

News and Trends 12 Apr 2016

How was the Biotech Financial World in 2015? Unprecedented!

Biotech is still breaking funding records. A new report by EY provides an interesting analysis of how Biotech is doing, globally and in Europe. Although 2015 was the best for Biotech yet, but there is a slowdown coming – that’s the gist of EY’s recent report: ‘Beyond borders 2016: Biotech financing‘. This well-known auditing and […]

April 12, 2016 - 3 minutesmins - By Denise Neves Gameiro

surgery background

News and Trends 11 Sep 2015

Biom’Up funding goes up Up UP! Surgery tech gets new pot of €31.3M VC

Biom’Up is a Lyon (Fr) Med-tech company which produces biopolymer devices to improve surgery. Launch of their new product Hemoblast has triggered a series C investment round from a large syndicate of European venture capitals. Biom’Up was founded in 2005, experiencing exponential growth since with their biopolymer tech development which achieved a €3M turnover in […]

September 11, 2015 - 2 minutesmins - By Dani Bancroft

IZB Germany investors

News and Trends 23 Jul 2015

Biotech investors are back in Germany

Things are looking good for German Biotechs! At least, this is what the general mood at the international congress organized by the IZB on July 16th and 17th 2015 in Martinsried, near Munich, reflected. A bunch of international investors and decision makers gathered to show that the sector is picking up momentum again in Germany! The Innovation and Startup […]

July 23, 2015 - 4 minutesmins - By Joachim Eeckhout

Oxford Science innovation google

News and Trends 28 Jun 2015

Google and big names helped Oxford Sciences Innovation to raise €457M

Oxford Sciences Innovation has completed the second close of its fundraising, raising an additional €157.3M (£110M) and bringing the total amount raised to €457.6M (£320M). This second close included some well-known investors such as Google Ventures and Charles Dunstone. Being backed by one of the best-recognized institutions in the world has its advantages. Oxford University […]

June 28, 2015 - 2 minutesmins - By Lourdes Riquelme

ADVERTISEMENT